See more : Alfi, Inc. (ALFIQ) Income Statement Analysis – Financial Results
Complete financial analysis of Wattanapat Hospital Trang Public Company Limited (WPH.BK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Wattanapat Hospital Trang Public Company Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Balfour Beatty plc (BAFYY) Income Statement Analysis – Financial Results
- Seaport Global Acquisition II Corp. (SGII) Income Statement Analysis – Financial Results
- Root, Inc. (ROOT) Income Statement Analysis – Financial Results
- RareJob Inc. (6096.T) Income Statement Analysis – Financial Results
- ACpay Co., Ltd. (6984.TWO) Income Statement Analysis – Financial Results
Wattanapat Hospital Trang Public Company Limited (WPH.BK)
About Wattanapat Hospital Trang Public Company Limited
Wattanapat Hospital Trang Public Company Limited operates hospitals and clinics in Thailand. The company operates medical clinics, including obstetrics and gynecology, surgery, internal medicine, pediatric, neurology, cardiology, eye, ENT, skin and beauty, dental, and wellness center, as well as X-Ray and MRI center, WPH emergency center, emergency center, kidney clinic and hemodialysis center, physical therapy clinic, gastrointestinal clinic, orthopedic clinic, and diabetes thyroid and endocrinology. Wattanapat Hospital Trang Public Company Limited was founded in 1957 and is headquartered in Trang, Thailand.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.46B | 1.15B | 1.23B | 705.47M | 754.47M | 625.87M | 533.31M | 542.00M | 476.54M | 430.86M |
| Cost of Revenue | 1.09B | 821.26M | 793.99M | 602.21M | 614.22M | 430.52M | 382.27M | 354.53M | 315.21M | 300.73M |
| Gross Profit | 366.10M | 324.24M | 432.30M | 103.26M | 140.24M | 195.36M | 151.05M | 187.47M | 161.33M | 130.13M |
| Gross Profit Ratio | 25.08% | 28.31% | 35.25% | 14.64% | 18.59% | 31.21% | 28.32% | 34.59% | 33.85% | 30.20% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 186.40M | 154.93M | 126.45M | 118.63M | 132.99M | 129.03M | 115.80M | 104.76M | 110.32M | 114.46M |
| Selling & Marketing | 35.17M | 18.74M | 16.55M | 16.10M | 18.37M | 15.83M | 15.03M | 11.19M | 5.08M | 2.23M |
| SG&A | 221.57M | 173.67M | 143.00M | 134.73M | 151.36M | 144.86M | 130.83M | 115.95M | 115.40M | 116.69M |
| Other Expenses | 0.00 | -7.59M | -7.08M | -4.95M | -4.96M | 3.75M | 3.67M | -9.73M | -2.94M | -4.05M |
| Operating Expenses | 221.57M | 166.09M | 135.91M | 129.77M | 146.41M | 141.11M | 127.16M | 106.22M | 112.46M | 112.64M |
| Cost & Expenses | 1.32B | 987.35M | 929.90M | 731.98M | 760.63M | 571.62M | 509.42M | 460.75M | 427.67M | 413.37M |
| Interest Income | 0.00 | 15.04M | 13.92M | 9.54M | 6.88M | 0.00 | 0.00 | 0.00 | 2.97K | 3.86K |
| Interest Expense | 42.22M | 15.04M | 13.92M | 9.54M | 6.88M | 1.92M | 5.15M | 7.56M | 6.69M | 10.04M |
| Depreciation & Amortization | 119.51M | 80.53M | 74.02M | 60.42M | 47.36M | 28.76M | 37.20M | 35.46M | 37.94M | 54.51M |
| EBITDA | 273.39M | 231.55M | 363.83M | 33.90M | 41.19M | 82.26M | 60.81M | 116.71M | 86.81M | 72.00M |
| EBITDA Ratio | 18.73% | 20.74% | 30.15% | 4.81% | 5.46% | 13.26% | 11.46% | 21.53% | 18.22% | 23.40% |
| Operating Income | 153.88M | 158.15M | 296.39M | -26.51M | -6.16M | 54.25M | 23.89M | 81.25M | 48.87M | -11.32M |
| Operating Income Ratio | 10.54% | 13.81% | 24.17% | -3.76% | -0.82% | 8.67% | 4.48% | 14.99% | 10.26% | -2.63% |
| Total Other Income/Expenses | -42.22M | -15.04M | -13.92M | -9.54M | -6.88M | -1.92M | -5.15M | -7.55M | -7.14M | -36.62M |
| Income Before Tax | 111.66M | 143.11M | 282.47M | -36.06M | -13.04M | 52.33M | 18.74M | 73.70M | 42.17M | -21.36M |
| Income Before Tax Ratio | 7.65% | 12.49% | 23.03% | -5.11% | -1.73% | 8.36% | 3.51% | 13.60% | 8.85% | -4.96% |
| Income Tax Expense | 16.61M | 27.82M | 40.68M | -2.37M | -6.56M | 1.93M | -5.13M | 1.70M | -1.29M | -4.75M |
| Net Income | 92.91M | 115.66M | 232.29M | -33.69M | -6.48M | 51.48M | 24.19M | 72.24M | 43.47M | -16.61M |
| Net Income Ratio | 6.37% | 10.10% | 18.94% | -4.78% | -0.86% | 8.22% | 4.54% | 13.33% | 9.12% | -3.86% |
| EPS | 0.15 | 0.19 | 0.38 | -0.06 | -0.01 | 0.09 | 0.05 | 0.17 | 0.10 | -0.03 |
| EPS Diluted | 0.15 | 0.19 | 0.38 | -0.06 | -0.01 | 0.09 | 0.05 | 0.16 | 0.07 | -0.03 |
| Weighted Avg Shares Out | 612.00M | 612.00M | 612.00M | 612.00M | 612.00M | 600.00M | 464.25M | 418.50M | 418.50M | 600.00M |
| Weighted Avg Shares Out (Dil) | 612.00M | 612.00M | 612.00M | 612.00M | 612.00M | 600.00M | 464.25M | 459.78M | 600.00M | 600.00M |
Source: https://incomestatements.info
Category: Stock Reports